The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-d-glucan in patients without risk factors for invasive fungal infections


Metan G. , Agkus C., Buldu H., KOÇ A. N.

INFECTION, cilt.38, sa.3, ss.217-221, 2010 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 38 Konu: 3
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1007/s15010-010-0003-6
  • Dergi Adı: INFECTION
  • Sayfa Sayıları: ss.217-221

Özet

The aim of this study was to investigate the interaction between intravenous piperacillin/tazobactam treatment and Aspergillus galactomannan antigen (GM) and 1,3-beta-d-glucan (BDG) test results in patients without known risk factors for invasive fungal infections (IFI).